Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature

Abstract Nivolumab may induce severe celiac‐like enteropathy, that may appear very rapidly, after only two injections of nivolumab, and may be successfully treated with corticosteroids. This observation underlines the importance of histological analysis of duodenal biopsies and the necessity to rule...

Full description

Bibliographic Details
Main Authors: Lucie Duval, Sarah Habes, Thierry Chatellier, Pascale Guerzider, Céline Bossard, Claude Masliah, Isabelle Archambeaud, Yann Touchefeu, Tamara Matysiak‐Budnik
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.2342
id doaj-58e2536996b5436781aa9b2f5d0bafee
record_format Article
spelling doaj-58e2536996b5436781aa9b2f5d0bafee2020-11-24T21:11:28ZengWileyClinical Case Reports2050-09042019-09-01791689169310.1002/ccr3.2342Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literatureLucie Duval0Sarah Habes1Thierry Chatellier2Pascale Guerzider3Céline Bossard4Claude Masliah5Isabelle Archambeaud6Yann Touchefeu7Tamara Matysiak‐Budnik8IMAD, Hepato‐Gastroenterology & Digestive Oncology Hôtel Dieu, CHU de Nantes Nantes FranceIMAD, Hepato‐Gastroenterology & Digestive Oncology Hôtel Dieu, CHU de Nantes Nantes FranceClinic of Estuaire Saint Nazaire FranceDepartment of Pathology Hospital of Saint Nazaire Saint Nazaire FranceDepartment of Pathology University Hospital of Nantes Nantes FranceClinic of Estuaire Saint Nazaire FranceIMAD, Hepato‐Gastroenterology & Digestive Oncology Hôtel Dieu, CHU de Nantes Nantes FranceIMAD, Hepato‐Gastroenterology & Digestive Oncology Hôtel Dieu, CHU de Nantes Nantes FranceIMAD, Hepato‐Gastroenterology & Digestive Oncology Hôtel Dieu, CHU de Nantes Nantes FranceAbstract Nivolumab may induce severe celiac‐like enteropathy, that may appear very rapidly, after only two injections of nivolumab, and may be successfully treated with corticosteroids. This observation underlines the importance of histological analysis of duodenal biopsies and the necessity to rule out a real celiac disease in patients with nivolumab‐induced diarrhea.https://doi.org/10.1002/ccr3.2342celiac‐like enteropathyimmune‐related adverse effectsimmunotherapynivolumabPD‐1 inhibitors
collection DOAJ
language English
format Article
sources DOAJ
author Lucie Duval
Sarah Habes
Thierry Chatellier
Pascale Guerzider
Céline Bossard
Claude Masliah
Isabelle Archambeaud
Yann Touchefeu
Tamara Matysiak‐Budnik
spellingShingle Lucie Duval
Sarah Habes
Thierry Chatellier
Pascale Guerzider
Céline Bossard
Claude Masliah
Isabelle Archambeaud
Yann Touchefeu
Tamara Matysiak‐Budnik
Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
Clinical Case Reports
celiac‐like enteropathy
immune‐related adverse effects
immunotherapy
nivolumab
PD‐1 inhibitors
author_facet Lucie Duval
Sarah Habes
Thierry Chatellier
Pascale Guerzider
Céline Bossard
Claude Masliah
Isabelle Archambeaud
Yann Touchefeu
Tamara Matysiak‐Budnik
author_sort Lucie Duval
title Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
title_short Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
title_full Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
title_fullStr Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
title_full_unstemmed Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
title_sort nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: case report and review of the literature
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2019-09-01
description Abstract Nivolumab may induce severe celiac‐like enteropathy, that may appear very rapidly, after only two injections of nivolumab, and may be successfully treated with corticosteroids. This observation underlines the importance of histological analysis of duodenal biopsies and the necessity to rule out a real celiac disease in patients with nivolumab‐induced diarrhea.
topic celiac‐like enteropathy
immune‐related adverse effects
immunotherapy
nivolumab
PD‐1 inhibitors
url https://doi.org/10.1002/ccr3.2342
work_keys_str_mv AT lucieduval nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT sarahhabes nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT thierrychatellier nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT pascaleguerzider nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT celinebossard nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT claudemasliah nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT isabellearchambeaud nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT yanntouchefeu nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
AT tamaramatysiakbudnik nivolumabinducedceliaclikeenteropathyinpatientwithmetastaticrenalcellcarcinomacasereportandreviewoftheliterature
_version_ 1716753244048326656